About the Tumor Biology and Immunology group

Our research is fundamental in nature and aims to delineate cellular and molecular processes that govern adaptive immunity, in particular the T cell response. Our main goal is to deliver knowledge that can rationally improve cancer immunotherapy strategies. At the same time, mechanisms we elucidate may be exploited to improve vaccination against infectious disease and to block undesired immune responses, as in auto-immunity and transplant rejection.